fashion -WSS

fashion

author：knowledge 2025-09-29 19:59:43 - browse：84

A caretaker speaks with an elderly Alzheimer's patient at a nursing home. — ALAIN JOCARD/AFP via Getty Images

For more than 30 years, Alzheimer’s researchers have thought of APOE4 as a major genetic risk factor for most cases of the devastating neurologic disease. But a new study published on Monday argues that this gene variant plays an even more important role than scientists had realized and causes a distinct form of Alzheimer’s.

Researchers analyzed data from more than 13,000 people, including nearly 800 APOE4 homozygotes, people who carry two copies of the gene variant. They found that nearly all of the homozygotes showed biological signs of Alzheimer’s in the brain, and they typically developed dementia and other symptoms, and died sooner, than people with Alzheimer’s who lack APOE4.

The research team also found that APOE4 homozygotes showed a predictable pattern of biomarker changes linked to Alzheimer’s, including a buildup of beta-amyloid and tau, a protein linked to neuron damage and death.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： FDA needs staff influx to meet gene therapy needs, Marks says

WSS

Brain injuries and the importance of a second opinion

Radiology is caught between AI's potential and concern for patients

What causes an itch? Researchers may have solved the mystery

Prime Medicine says its gene editing passes test in monkeys

What PEPFAR has meant on the ground in Ukraine

FDA needs staff influx to meet gene therapy needs, Marks says

Wikipedia

fashion

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

explore

What does generative AI mean for health care? We asked experts

What is microchimerism and how does it affect maternal health?

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Pharma patents targeted by Biden in move to slash drug prices

Walensky prepares to leave CDC — and Congress — behind

Roche to buy Carmot Therapeutics, developer of obesity drugs

Medicare proposal to cover medical devices draws a mixed reaction

Infant mortality in U.S. rose last year for first time in decades: CDC

How to save PrEP access — and even expand it

Bill would allow buprenorphine prescription for addiction via telehealth

leisure time

Despite FDA approval for Lyfgenia, Bluebird faces stiff competition

Leukemia patients are helped by Syndax's new type of therapy

Infant mortality in U.S. rose last year for first time in decades: CDC

How neuroscience research could help beat back brain cancer

AI models in health care face new federal disclosure requirements

Sarepta Duchenne therapy fails to meet primary endpoint in trial

entertainment

Wikipedia

hotspot

hotspot